Protalix BioTherapeutics, Inc.

PLX · XNYS

CIK 1006281fmd_0SFC1X80RXG85Y60XSEEENE0R5Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2009 to Sep 30, 2026, 67 periods

Ratios computed from the standardized statements. Select a value to open its proof.